Kunstherzen (TAH)

  • U. Boeken
  • A. Assmann
  • F. Born
  • C. Schmid


Bei Patienten mit terminaler Herzinsuffizienz ist die orthotope Herztransplantation (HTx) zu einem chirurgischen Routineeingriff geworden. Der Mangel an Spenderorganen und der damit verbundene kontinuierliche Anstieg der Wartezeit bis zur HTx haben zu einer 15–30%igen Mortalitätsrate pro Jahr auf der Warteliste geführt.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


Literatur zu 5.1

  1. Abraham WT, Adamson PB, Bourge RC et al. (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:658-666PubMedCrossRefGoogle Scholar
  2. Akutsu T, Kolff WJ (1958) Permanent substitutes for valves and hearts. Trans Am Soc Artif Intern Organs 4:230-235Google Scholar
  3. Anderson FL, DeVries WC, Anderson JL et al. (1984) Evaluation of total artificial heart performance in man. Am J Cardiol 54:394-398PubMedCrossRefGoogle Scholar
  4. Annas GJ (1986) Made in the USA:legal and ethical issues in artificial heart transplantation. Law Med Health Care 14:164-171PubMedGoogle Scholar
  5. Artificial heart assessment panel (1973) The totally implantable artificial heart: Economic, ethical, legal, medical, psychatric and social implications. National Heart and Lung Institute of DHEW. Washington, DC:US Government Printing OfficeGoogle Scholar
  6. Bramstedt KA (2003) Contemplating total artificial heart inactivation in case of futility. Death Studies 27:295-304PubMedCrossRefGoogle Scholar
  7. Chiang BY, Olsen DB, Gaykowski R et al. (1984) Evaluation of treadmill exercise on total artificial heart recipients. Trans Am Soc Artif Intern Organs 30:514-519PubMedGoogle Scholar
  8. Cooley DA, Liotta D, Hallman GL et al (1969) Orthotopic cardiac prothesis for two-staged cardiac replacement. Am J Cardiol 24:723-730PubMedCrossRefGoogle Scholar
  9. Cooley DA, Akutsu T, Norman JC et al (1981) Total artificial heart in two-staged cardiac transplantation. Cardiovasc Dis, Bull Tex Heart Inst 8:305-319Google Scholar
  10. Copeland JG, Arabia FA, Tsau PH et al (2003) Total artificial hearts: Bridge to transplantation. Cardiol Clin 21:101-113PubMedCrossRefGoogle Scholar
  11. Copeland JG, Levinson MM, Smith R et al (1986) The total artificial heart as a bridge to transplantation: a report of two cases. JAMA 256:2991-2995PubMedCrossRefGoogle Scholar
  12. Copeland JG, Smith RG, Arabia FA et al. (2004) Cardiac replacement with a total artificial heart as a bridge to transplantation. NEJM 351:859-867PubMedCrossRefGoogle Scholar
  13. Copeland JG, Smith RG, Bose RJ et al (2008) Risk factor analysis for bridge to transplantation with the CardioWest total artificial heart. Ann Thorac Surg 85:1639-1645PubMedCrossRefGoogle Scholar
  14. DeBakey ME (1971) Left ventricular bypass pump for cardiac assistance: clinical experience. Am J Cardiol 3-11Google Scholar
  15. DeVries WC (1988) The permanent artificial heart: four case reports. JAMA 259:849-859PubMedCrossRefGoogle Scholar
  16. De Vries WC, Anderson JH, Joyce LD et al. (1984) Clinical use of the total artificial heart. N Engl J Med 310(5):273-278CrossRefGoogle Scholar
  17. Drakos SG, Kfoury AG, Gilbert EM et al. (2007) Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. Ann Thorac Surg 83:62-67PubMedCrossRefGoogle Scholar
  18. El-Banayosy A, Arusoglu L, Morshuis M et al. (2005) CardioWest Total Artificial Heart: Bad Oeynhausen experience. Ann Thorac Surg 80:548-552PubMedCrossRefGoogle Scholar
  19. El-Banayosy A, Arusoglu L, Morshuis M et al. (2007a) Portable Drivers for a total artificial heart. J Heart Lung Transplant 26 (2):S201CrossRefGoogle Scholar
  20. El-Banayosy A, Morshuis M, Arusoglu L et al. (2007b) Out of hospital treatment in patients with a total artificial heart. J Heart Lung Transplant 26 (2):S87CrossRefGoogle Scholar
  21. Everett J, Murray K, Brown V et al. (1989) The effect of graded exercise on cardiac output of the Jarvik-7-70 total artificial heart in humans. ASAIO Transactions 35:231-234PubMedCrossRefGoogle Scholar
  22. Frazier OH, Macris MP 1994 Current methods for circulatory support. Texas Heart Institute Journal 21:288-295PubMedGoogle Scholar
  23. Gaitan BD, Thunberg CA, Stansbury LG et al. (2011) Development, Current status, and anesthetic management of the implanted artificial heart. J Cardiothor Vasc Anesth 25:1179-1192CrossRefGoogle Scholar
  24. Hansson SO (2005) Implant ethics. J Med Ethics 31:519-525PubMedCrossRefGoogle Scholar
  25. Henning E, Grobe-Siestrup C, Krautzberger W et al. (1978) The relationship of cardiac output and venous pressure in long surviving calves with total artificial heart. Trans Am Soc Artif Intern Organs 24:616-624Google Scholar
  26. Honda T, Nagai I, Nitta S et al. (1975) Evaluation of cardiac function and venous return curves in awake, unanesthized calves with an implanted total artificial heart. Trans am Soc Artif Intern Organs 21:362-367PubMedGoogle Scholar
  27. Jaroszewski DE, Anderson EM, Pierce CN et al. (2011) The SynCardia freedom driver: A portable driver for discharge home with the total artificial heart. J Heart Lung Transplant 30(7):844-845PubMedCrossRefGoogle Scholar
  28. Jauhar S (2004) The artificial heart. NEJM 350:542-544PubMedCrossRefGoogle Scholar
  29. Johnson KE, Prieto M, Joyce LD et al (1992) Summary of the clinical use of the Symbion total artificial heart: a registry report. J Heart Lung Transplant 11(1):103-116PubMedGoogle Scholar
  30. Joyce LD, DeVries WC, Hastings WL et al (1983) Response of the human body to the first permanent implant of the Jarvik-7 total artificial heart. Trans Am Soc Artif Intern Organs 29:81-87PubMedGoogle Scholar
  31. Joyce DL, Southard RE, Torre-Amione G et al. (2005) Impact of left ventricular assist device (LVAD)- mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant 24:2054-2059PubMedCrossRefGoogle Scholar
  32. Jurmann MJ, Weng Y, Drews T et al. (2004) Permanent mechanical circulatory support in patients of advanced age. Eur J Cardiothorac Surg 25:610-618PubMedCrossRefGoogle Scholar
  33. Kito Y, Honda T, Gibson WH et al. (1974) Hemodynamic studies during exercise in calves with total artificial heart Trans Am Soc Artif Intern Organs 20:667-672PubMedGoogle Scholar
  34. Körfer R (2008) Invited commentary. Ann Thorac Surg 85:1645CrossRefGoogle Scholar
  35. Körfer R, El-Banayosy A, Morshuis M et al. (2007) Total artificial heart-implantation technique using the CardioWest or the Thoratec system. Multiman CardioThorac Surg 3:1-9; doi:10.1510/mmcts.s006.002485Google Scholar
  36. Kohli HS, Canada J, Arena R et al. (2011) J Heart Lung Transplant 30:1207-1213PubMedCrossRefGoogle Scholar
  37. Kolff WJ, DeVries WC, Joyce LD et al (1983) Lessons learned from DR. Barney Clark in the first patient with an artificial heart. Int J Artif Organs 1:165-174Google Scholar
  38. Leprince P, Bonnet N, Varnous S et al. (2005) Patients with a body surface area less than 1.7 m2 have a good outcome with the CardioWest Total Artificial Heart. J Heart Lung Transplant 24(10):1501-1505PubMedCrossRefGoogle Scholar
  39. Lunn JK, Liu WS, Stanley TH et al. (1976) Effects of treadmill exercise on cardiovascular and respiratory dynamics before and after artificial heart implantation Trans Am Soc Artif Intern Organs 22:315-322PubMedGoogle Scholar
  40. Massad MG, Cook DJ, Schmitt SK et al. (1997) Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 64:1120-1125PubMedCrossRefGoogle Scholar
  41. Miles SH, Siegler M, Schiedermayer DL (1988) The Total Artificial Heart: An etchics perspective on current clinical research and deployment. CHEST 94:409-413PubMedCrossRefGoogle Scholar
  42. Moazami N, Itescu S, Williams MR et al. (1998) Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant 17:876-880PubMedGoogle Scholar
  43. Muneretto C, Solis E, Pavie A (1989) Total artificial heart: Survival and complications. Ann Thorac Surg 47:151-157PubMedCrossRefGoogle Scholar
  44. Myers TJ, Robertson K, Pool T et al (2003) Continuous flow pumps and total artificial hearts. Management issues. Ann Thorac Surg 75:79-85CrossRefGoogle Scholar
  45. Nativi JN, Drakos SG, Kucheryavaya AY et al. (2011) Changing outcomes in patients bridged to heart transplantation with continuous-versus pulsatile-flow ventricular assist devices: An analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 30(8):854-861PubMedGoogle Scholar
  46. Nolan PE, Smith RG, Slepian MJ et al. (2008) Low likelihood for developing cytotoxic antibodies during implantation with the CardioWest Total Artificial Heart. J Heart Lung Transplant 27:S161CrossRefGoogle Scholar
  47. Norman JC, Cooley DA, Kahan BD et al (1978) Total support of the circulation of a patient with postcardiotomy stone-heart syndrom supported by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet 1:1125-1127PubMedCrossRefGoogle Scholar
  48. OConnor MJ, Menteer JD, Chrisant MRK et al. (2010) Ventricular assist device-associated antihuman leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation. J Heart Lung Transplant 29:109-116CrossRefGoogle Scholar
  49. Pagani FD, Dyke DB, Wright S et al. (2001) Development of anti-major histocompatibility complex class I and II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival. J Heart Lung Transplant 20:646-653PubMedCrossRefGoogle Scholar
  50. Patlolla V, Patten RD, DeNofrio D et al. (2009) The effect of ventricular assist devices on post-transplant mortality. J Am Coll Cardiol 53:264-271PubMedCrossRefGoogle Scholar
  51. Phillips R, Lichtenthal P, Sloniger J et al (2009) Noninvasive cardiac output measurement in heart failure subjects on circulatory support. Anesth Analg 108:881-886PubMedCrossRefGoogle Scholar
  52. Reemtsma K, Krusin R, Edie R et al (1978) Cardiac transplantation in patients requiring mechanical circulatory support. N Engl J Med 298:670-671PubMedCrossRefGoogle Scholar
  53. Schulze B, Tenderich G, Schulz U et al. (2001) Einfluss verschiedener, mechanischer Unterstützungssysteme auf die Ergebnisse nach orthotoper Herztransplantation Z Herz- Thorax- Ge- fäßchir 15:103-110CrossRefGoogle Scholar
  54. Shah KB, Tang DG, Cooke RH et al. (2011) Implantable mechanical circulatory support: Demystifying patients with ventricular assist devices and artificial hearts. Clin Cardiol 34:147-152PubMedCrossRefGoogle Scholar
  55. Stehlik J, Edwards LB, Kucheryavaya AY et al. (2011) The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report-2011. J Heart Lung Transplant 30(10):1078-1094PubMedCrossRefGoogle Scholar
  56. Stepanenko A, Potapov EV, Drews T et al. (2010) Home discharge with CardioWest-t Total artificial Heart - Single center experience. J Heart Lung Transplant 29(2):S90CrossRefGoogle Scholar
  57. Spanier TB, Rose S, Schmitt AM et al. (1996) Interactions between dendritic cells and T-cells on the surface of left ventricular assist devices leads to TH2 pattern of cytokine production and B-cell hyperreactivity in vivo. Circulation 94(suppl. I):I-293 (abstract)Google Scholar
  58. Szefner J, Cabrol C (1993) Control and treatment of hemostasis in patients with a total artificial heart: the experience at La Pitie. In: Piffare R, editors. Anticoagulation, hemostasis and blood preservation in cardiovascular surgery. Philadelphia: Hanley and Belfus: p. 237-264Google Scholar
  59. Uchida N, Ishikawa M, Watanabe T et al. (1987) Hemodynamic adaptation to exercise after total artificial heart (TAH) implantation. Trans Am Soc Artif Intern Organs 33:240-244Google Scholar
  60. US Food and Drug Administration. New Device Approval-SynCardia temporary CardioWest total artificial heart (TAH-t): P030011 (, Posted: 11-03-2004. Last checked: 01-03-2012)
  61. Van Mawijk K, Van Prooijen HC, Moes M et al. (1991) Use of leukocyte-depleted platelet concentrations for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood 77:201-205Google Scholar
  62. Veatch RM (2003) Inactivating a total artificial heart: special moral problems. Death Studies 27:305-315PubMedCrossRefGoogle Scholar
  63. Verdejo HE, Castro PF, Concepciön R et al. (2007) Comparison of a radiofrequency-based wireless pressure sensor to Swan-Ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. JACC 50:2375-2382PubMedCrossRefGoogle Scholar
  64. Yoda M, ElBanayosy A, Tenderich G et al. (2009) The CardioWest Total Artificial Heart for chronic heart transplant rejection. Circ J 73:1167-1168PubMedCrossRefGoogle Scholar
  65. Zhang B, Masuzawa T, Tatsumi E et al. (1999) Three-dimesional thoracic modelling for an anatomical compatibility study of the implantable total artificial heart. Artificial Organs 23:229-234PubMedCrossRefGoogle Scholar
  66. Zimmermann H, Coehlo-Anderson R, Slepian M et al. (2010) Device malfunction of the CardioWest total artificial heart secondary to catheter entrapment of the tricuspid valve. ASAIO J 56:481-482CrossRefGoogle Scholar

Literatur zu 5.2

  1. Arusoglu L, Reiss N, Morshuis M et al. (2010) The Thoratec system implanted as a modified total artificial heart: the Bad Oeynhausen technique. Heart Sur Forum 1142:E391-E393CrossRefGoogle Scholar
  2. ElBanayosy A, Arusoglu L, Morshuis M et al. (2003) Novel application of Thoratec VAD as a para-corporeal total artificial heart. J Heart Lung Transpl 22(1S):S198-S199CrossRefGoogle Scholar
  3. Körfer R, ElBanayosy A, Morshuis M et al. (2007) Total artificial heart-implantation technique using the CardioWest or the Thoratec system. Multiman CardioThorac Surg; doi:10.1510/mmcts. s006.002485Google Scholar
  4. Krabatsch T, Potapov E, Stepananko A et al. (2011) Biventricular support with two miniaturized implantable assist devices. Circulation 124(suppl 1):S179-S186CrossRefGoogle Scholar
  5. Ricci M, Panos AL, Andreopoulos FM et al. (2009) Successful use of a custom-made paracorporeal total artificial heart as a bridge to retransplantation in adult and adolescent patients. J Heart Lung Transpl 28(8): 834-837CrossRefGoogle Scholar
  6. Stepanenko A, Hennig E, Potapov EV (2010) Long-term biventricular support with the HeartWare implantable continuous flow pump. J Heart Lung Transpl 29(7):822-824CrossRefGoogle Scholar

Literatur zu 5.3

  1. Copeland JG (2000) Bridge to transplantation: selection and timing. Transplant Proceed 32(7): 1535-1536CrossRefGoogle Scholar
  2. Körfer R, El-Banayosy A, Morshuis M et al. (2007) Total artificial heart-implantation technique using the CardioWest or the Thoratec system. Multiman CardioThorac Surg 3:1-9; doi:10.1510/mmcts.s006.002485Google Scholar
  3. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW et al (2001) Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group 2001. Long-term mechanical left ventricular assistance for end-stage heart failure. New EngJ Med 345(20): 1435-1443CrossRefGoogle Scholar
  4. Samuels L (2004) Biventricular mechanical replacement. Surg Clin North Am 84(1): 309-321PubMedCrossRefGoogle Scholar
  5. Sezai A, Arusoglu L, Minami K, El-Banayosy A, Korfer R (2002) Implantation of biventricular assist devices for chronic heart transplant rejection. Ann Thorac Surg 74(2): 609-611PubMedCrossRefGoogle Scholar
  6. Tjan TDT, Klotz S, Schmid C, Scheld HH (2008) Creation of a self-made total artificial heart using combined components of available ventricular assist devices. Thorac Cardiovasc Surg 56(1): 51-53PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • U. Boeken
    • 1
  • A. Assmann
    • 1
  • F. Born
    • 2
  • C. Schmid
    • 3
  1. 1.Klinik für Kardiovaskuläre ChirurgieUniversitätsklinikum DüsseldorfDüsseldorf
  2. 2.Herzchirurgische Klinik und PoliklinikKlinikum der Universität München – GroßhadernMünchen
  3. 3.Klinik für Herz-, Thorax- und herznahe GefäßchirurgieUniversitätsklinikum RegensburgRegensburg

Personalised recommendations